IRIS
GHIORZO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.223
AS - Asia 2.399
NA - Nord America 1.552
SA - Sud America 181
AF - Africa 30
OC - Oceania 13
Totale 26.398
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.793
US - Stati Uniti d'America 1.461
SG - Singapore 965
CN - Cina 632
VN - Vietnam 403
FR - Francia 185
BD - Bangladesh 159
BR - Brasile 111
HK - Hong Kong 84
FI - Finlandia 67
DE - Germania 50
CA - Canada 44
AR - Argentina 35
JP - Giappone 32
GB - Regno Unito 25
CH - Svizzera 24
MX - Messico 23
IQ - Iraq 22
IN - India 17
NL - Olanda 17
AU - Australia 13
RU - Federazione Russa 11
ID - Indonesia 10
PL - Polonia 8
UZ - Uzbekistan 8
CL - Cile 7
EC - Ecuador 6
MA - Marocco 6
PK - Pakistan 6
SA - Arabia Saudita 6
VE - Venezuela 6
CO - Colombia 5
ES - Italia 5
GR - Grecia 5
IE - Irlanda 5
TR - Turchia 5
ZA - Sudafrica 5
AT - Austria 4
AZ - Azerbaigian 4
IR - Iran 4
JO - Giordania 4
KR - Corea 4
MY - Malesia 4
PH - Filippine 4
TH - Thailandia 4
UA - Ucraina 4
UY - Uruguay 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
LT - Lituania 3
NI - Nicaragua 3
OM - Oman 3
PY - Paraguay 3
DO - Repubblica Dominicana 2
ET - Etiopia 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
SE - Svezia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BM - Bermuda 1
BO - Bolivia 1
CY - Cipro 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
Totale 26.398
Salva come PNG Salva come JPEG
Città #
Genova 12.035
Genoa 6.107
Rapallo 1.921
Vado Ligure 1.471
Singapore 427
San Jose 422
Ashburn 245
Lauterbourg 177
Council Bluffs 132
Ho Chi Minh City 128
Beijing 106
Hanoi 88
New York 85
Hong Kong 80
Helsinki 63
Bordighera 46
Santa Clara 45
Frankfurt am Main 43
Milan 33
Tokyo 24
Los Angeles 21
Zurich 21
São Paulo 19
Haiphong 18
Rome 17
Buffalo 14
Dallas 14
Tianjin 14
Baghdad 13
Boardman 13
Mexico City 13
Montreal 13
Chicago 12
Da Nang 11
London 11
Orem 11
San Francisco 10
Amsterdam 9
Atlanta 9
Bologna 9
Biên Hòa 7
Hải Dương 7
Toronto 7
Warsaw 7
Denver 6
Des Moines 6
Guangzhou 6
Houston 6
Naples 6
Phoenix 6
Athens 5
Brasília 5
Buenos Aires 5
Can Tho 5
Catania 5
Dublin 5
Phủ Lý 5
Tashkent 5
Thái Nguyên 5
Vienna 5
Baku 4
Charlotte 4
Chennai 4
Florence 4
Hưng Yên 4
Land O' Lakes 4
Lappeenranta 4
Mumbai 4
Quảng Ngãi 4
Quận Ba 4
Rio de Janeiro 4
Shenzhen 4
Venice 4
Amman 3
Asunción 3
Brooklyn 3
Brugherio 3
Cagliari 3
City of London 3
Curitiba 3
Guatemala City 3
Hangzhou 3
Indianapolis 3
Kyiv 3
Managua 3
Manchester 3
Miami 3
Modena 3
Nha Trang 3
Ninh Bình 3
Nuremberg 3
Palermo 3
Prague 3
Queens 3
Quận Bình Thạnh 3
Riyadh 3
Rudolfstetten 3
Salvador 3
Santiago 3
Seattle 3
Totale 24.197
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 252
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 241
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 237
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. 232
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 222
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 217
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 213
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 211
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 210
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 210
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 210
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 208
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 205
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 205
Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1 202
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project. 199
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 197
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 197
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 196
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 195
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma 195
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 193
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma 193
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 191
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 191
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 189
The effect on melanoma risk of genes previously associated with telomere length. 188
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 186
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 186
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 185
PCCR: Pancreatic Cancer Collaborative Registry. 184
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 183
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 183
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 183
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 183
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 182
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 182
Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant 181
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 173
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 173
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 172
A variant in FTO shows association with melanoma risk not due to BMI. 172
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 171
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 170
Identification, genetic testing, and management of hereditary melanoma 169
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 169
Molecular characterization of an Italian series of sporadic GISTs. 167
Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study. 167
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 163
Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma. 163
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 162
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 160
Genome-wide association study identifies three new melanoma susceptibility loci 160
Mutational concordance between primary and metastatic melanoma: A next-generation sequencing approach 159
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 157
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer 157
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 156
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 155
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 153
Signs and genetics of rare cancer syndromes with gastroenterological features 153
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 153
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 153
Current State of Target Treatment in BRAF Mutated Melanoma 153
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 152
Genetic testing for melanoma 152
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 152
MelaNostrum: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 151
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 150
Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk. 150
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 149
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 148
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 146
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 146
Identification of a SUFU germline mutation in a family with Gorlin syndrome 145
The 5′-untranslated region of p16INK4a acts as a cellular IRES, controls mRNA translation during hypoxic and energetic stresses, and is a target of YBX1 145
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 145
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 145
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 144
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 144
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 144
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 143
Linkage Analysis in melanoma prone families 142
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 142
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 141
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 141
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 140
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 140
Characterization of Ligurian Melanoma families and risk of occurence of other neoplasia 140
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 139
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 138
Mutation screening of the CDKN2A promoter melanoma families 137
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 137
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 137
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. 137
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 137
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies 135
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families 135
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 134
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 134
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations 134
Totale 16.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.866
article - articoli 76.502
book - libri 0
conference - conferenze 11.219
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.145
Totale 177.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021143 0 0 0 0 0 0 0 0 0 0 0 143
2021/20222.200 94 174 130 244 90 169 166 495 94 209 83 252
2022/20232.338 269 153 25 235 430 362 17 187 385 16 217 42
2023/20241.268 52 153 20 139 76 205 96 76 97 36 76 242
2024/20253.762 121 266 150 275 472 365 402 601 170 172 300 468
2025/20267.093 734 260 888 563 828 663 1.011 273 559 688 534 92
Totale 26.915